Daxor Cash on Hand 2010-2011 | DXR

Daxor cash on hand from 2010 to 2011. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Daxor Annual Cash on Hand
(Millions of US $)
2011 $56
2010 $54
2009 $54
Daxor Quarterly Cash on Hand
(Millions of US $)
2011-12-31 $56
2011-09-30 $52
2011-06-30 $54
2011-03-31 $53
2010-12-31 $54
2010-09-30 $58
2010-06-30 $49
2010-03-31 $76
2009-12-31 $54
2009-09-30 $70
2009-06-30 $70
2009-03-31 $58
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.036B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.711B 19.42
Encompass Health (EHC) United States $11.842B 25.10
DaVita (DVA) United States $11.065B 14.69
Chemed (CHE) United States $8.448B 26.55
Elanco Animal Health (ELAN) United States $5.962B 12.78
Option Care Health (OPCH) United States $5.476B 24.41
RadNet (RDNT) United States $4.123B 87.25
Amedisys (AMED) United States $3.155B 21.22
LifeStance Health (LFST) United States $2.143B 0.00
Addus HomeCare (ADUS) United States $2.066B 22.68
Astrana Health (ASTH) United States $1.802B 36.11
U.S Physical Therapy (USPH) United States $1.078B 28.61
Pennant (PNTG) United States $0.957B 35.14
Aveanna Healthcare Holdings (AVAH) United States $0.940B 0.00
Atai Life Sciences (ATAI) Germany $0.278B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00